Taviratx
1 known investors
Find your way into Taviratx
59 people in our graph share verified history with the Taviratx team — schools, employers, funds. One of them is your warm intro.
Katrin Geyskensunlockedknows Inge Van Hove · together at KU Leuven (overlapped)
×8knows the team · via KU Leuven
×3knows the team · via Hasselt University
Tavira Therapeutics develops an AAV delivery platform for gene therapy that uses modular, post-manufacture enzymatic modification of AAV vectors to target intended tissues more accurately. The technology aims to improve delivery efficiency of AAV vector cargo to the right cells and reduce unintended side effects.
Founders & leadership
EH
Els HenckaertsCo-founder
BM
Benjamien MoeyaertinCo-founder
VB
Veronick BenoyinCo-founder
VK
Vibha Kiran TamboliCo-founder
IV
Inge Van HoveinCo-founderInge Van Hove is a co-founder of Tavira Therapeutics and brings over 10 years of biotech experience with scientific expertise in neuroscience, ophthalmology, and gene therapy, including contributions to more than 30 peer-reviewed publications.
Investors · 1
Frequently asked questions
- What does Taviratx do?
- Tavira Therapeutics develops an AAV delivery platform for gene therapy that uses modular, post-manufacture enzymatic modification of AAV vectors to target intended tissues more accurately. The technology aims to improve delivery efficiency of AAV vector cargo to the right cells and reduce unintended side effects.
- Who founded Taviratx?
- Taviratx was founded by Els Henckaerts, Benjamien Moeyaert, Veronick Benoy, Vibha Kiran Tamboli, Inge Van Hove.
- Who are Taviratx's investors?
- Taviratx's investors include GENERAL INCEPTION.